Hyperfunction of pituitary gland

E4_HYPERPIT

hyperpituitarism: Disease of the glandular, anterior portion of the pituitary (pituitary gland, anterior) resulting in hypersecretion of adenohypophyseal hormones such as growth hormone; prolactin; thyrotropin; luteinizing hormone; follicle stimulating hormone ; and adrenocorticotropic hormone. Hyperpituitarism usually is caused by a functional adenoma.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E22 Cause of death: ICD-10 — E22 2 out of 7 registries used, show all original rules.	1821
4. Check minimum number of events None	1821
5. Include endpoints E4_ACROMEG E4_HYPERPRO E4_ANTIDIU E4_PRECOXCENTPUB E4_HYPERPITNAS	2009
6. Filter based on genotype QC (FinnGen only)	2009

Control definitions (FinnGen only)

Control exclude: E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E20-E35
Name in latin: Hyperfunctio hypophysis

NAME	E4_HYPERPIT
CONTROL_EXCLUDE	E4_ENDOGLAND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_ACROMEG\|E4_HYPERPRO\|E4_ANTIDIU\|E4_PRECOXCENTPUB\|E4_HYPERPITNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E22
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E22
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hyperfunction of pituitary gland based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13775	10007	3602
Only index persons	12382	9265	3117
Unadjusted period prevalence (%)
Whole population	0.24	0.29	0.10
Only index persons	0.28	0.34	0.12
Median age at first event (years)
Whole population	36.03	32.93	44.58
Only index persons	35.04	32.51	42.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2009	1527	482
Unadjusted period prevalence (%)	0.45	0.52	0.21
Median age at first event (years)	37.79	34.06	49.60

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1832: Matched controls
18321

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G02CB01

ATC

bromocriptine; systemic

44.5

323.0

473

142

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

310.7

323.0

372

E22.1

ICD-10 Finland

Hyperprolactinaemia

10361.8

323.0

1235

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

396.3

323.0

514

N04BC06

ATC

cabergoline; oral (dopamine agonists)

792.5

323.0

428

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

+∞

210.6

198

G02CB03

ATC

cabergoline; oral (prolactine inhibitors)

87.3

169.2

188

H02AB09

ATC

hydrocortisone; systemic

25.5

162.0

231

103

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

+∞

159.8

151

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

529.7

149.8

147

101

Kela drug reimbursment

Anterior pituitary hypofunction

+∞

135.1

128

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

99.9

E22.80

ICD-10 Finland

Central precocious puberty

+∞

94.6

N91.1

ICD-10 Finland

Secondary amenorrhoea

9.5

74.8

160

183

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

9.9

71.9

150

164

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

249.6

70.8

G02CB04

ATC

quinagolide; oral

328.1

63.8

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.2

61.8

254

669

N05AX08

ATC

risperidone; systemic

4.5

61.3

236

583

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

213.8

60.5

E22.9

ICD-10 Finland

Hyperfunction of pituitary gland, unspecified

+∞

52.3

H03AA01

ATC

levothyroxine sodium; systemic

2.5

52.2

517

2506

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

7.7

51.1

123

170

H01CB02

ATC

octreotide; parenteral

251.6

48.3

G03DB01

ATC

dydrogesterone; oral

2.7

47.8

391

1693

2531A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]

+∞

46.0

2594A

ICD-9 Finland

Other endocrine disorders, Dwarfism, not elsewhere classified

+∞

45.0

N05AH03

ATC

olanzapine; systemic

3.9

43.8

195

546

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

71.7

43.2

102

Kela drug reimbursment

Diabetes insipidus

+∞

42.9

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

5.4

42.6

134

264

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

+∞

41.8

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

+∞

39.7

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

107.4

38.9

H01AC01

ATC

somatropin; parenteral

+∞

38.7

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

136.2

37.9

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.5

37.7

141

335

N05AH04

ATC

quetiapine; oral

2.3

37.3

395

1935

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

193.9

36.9

H01CB03

ATC

lanreotide; parenteral

97.0

34.8

N05AX12

ATC

aripiprazole; systemic

4.0

34.2

144

382

E23.05

ICD-10 Finland

Lack of TSH

332.9

33.0

Z51.80

ICD-10 Finland

Manipulation of puberty development with hormone therapy

+∞

31.3

2530A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]

+∞

31.3

E30.1

ICD-10 Finland

Precocious puberty

+∞

31.3

N04BC01

ATC

bromocriptine; oral

162.8

30.8

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

18.1

29.7

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.8

28.6

646

4217

2542

FHL

Transasal hypophysectomy

+∞

28.2

N05AB03

ATC

perphenazine; systemic, rectal

4.4

28.0

104

245

AA1AD

NOMESCO Finland

CT of head and brain

2.1

28.0

350

1825

XCK00

NOMESCO Finland

Perimetry

3.4

27.2

137

422

N05AH02

ATC

clozapine; systemic

5.2

27.2

171

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

27.1

186

708

ZXC86

NOMESCO Finland

Use of endoscopic device

15.5

26.9

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

6.4

26.7

114

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.8

24.6

182

N03AG01

ATC

valproic acid; systemic, rectal

3.0

24.0

149

533

N05AA02

ATC

levomepromazine; systemic

3.8

23.9

104

284

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

11.6

23.2

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

10.5

23.1

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.3

23.0

229

1069

N05BA06

ATC

lorazepam; systemic, sublingual

3.6

22.9

108

316

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.1

22.9

276

1406

XLA10

NOMESCO Finland

3.0

22.6

139

492

N06AB04

ATC

citalopram; systemic

1.9

22.4

396

2340

UJF32

NOMESCO Finland

Coloscopy

1.9

21.9

385

2268

25300

ICD-8 Finland

Diseases of pituitary gland, Aeromegalia

+∞

21.9

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.2

21.7

N06AX16

ATC

venlafaxine; oral

2.0

21.0

298

1617

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

+∞

20.9

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.7

20.6

152

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

20.4

274

1456

L02AE02

ATC

leuprorelin; implant, parenteral

3.7

20.1

253

E22.88

ICD-10 Finland

Other hyperfunction of pituitary gland

+∞

19.8

2590A

ICD-9 Finland

Other endocrine disorders, Delay in sexual development and puberty, not elsewhere classified

+∞

19.8

2591A

ICD-9 Finland

Other endocrine disorders, Precocious sexual development and puberty, not elsewhere classified

+∞

19.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

19.7

447

2852

N97.9

ICD-10 Finland

Female infertility, unspecified

2.5

19.6

161

677

N04AA02

ATC

biperiden; systemic

4.9

19.3

131

N05CD07

ATC

temazepam; oral

2.4

19.2

173

766

N05BA04

ATC

oxazepam; oral

1.7

19.1

439

2811

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

19.0

598

4186

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.8

18.9

124

459

P72

ICPC

Schizophrenia

5.0

18.8

126

E23.6

ICD-10 Finland

Other disorders of pituitary gland

+∞

18.8

N03AX09

ATC

lamotrigine; oral

2.7

18.4

128

490

N97.0

ICD-10 Finland

Female infertility associated with anovulation

4.1

18.2

177

E21.0

ICD-10 Finland

Primary hyperparathyroidism

37.1

17.6

R51.80

ICD-10 Finland

Headache

1.8

17.2

305

1790

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.0

17.0

174

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

17.0

174

821

E23.03

ICD-10 Finland

Lack of ACTH

+∞

16.7

E23.2

ICD-10 Finland

Diabetes insipidus

90.9

16.6

C07AA05

ATC

propranolol; systemic

1.7

16.5

370

2337

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

16.5

365

2296

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

16.1

420

2767

N06AX11

ATC

mirtazapine; oral

1.6

15.7

529

3727

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

+∞

15.6

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.5

15.6

R11

ICD-10 Finland

Nausea and vomiting

2.3

15.5

154

716

R53

ICD-10 Finland

Malaise and fatigue

1.7

15.4

349

2204

N05CF01

ATC

zopiclone; oral

1.6

15.4

469

3220

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.9

15.4

165

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

15.4

346

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

15.4

221

1198

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

15.3

411

2724

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.7

15.2

103

391

N06AB03

ATC

fluoxetine; oral

1.9

15.2

229

1266

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.4

14.9

122

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

57.2

14.8

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

9.2

14.7

N05AF03

ATC

chlorprothixene; systemic

3.5

14.6

204

D352, E221

ICD-10 Finland

+∞

14.6

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

14.5

264

1557

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

14.4

232

1309

C03CA01

ATC

furosemide; systemic

1.8

14.4

283

1713

G47.3

ICD-10 Finland

Sleep apnoea

1.8

14.2

290

1773

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

14.0

349

2262

N05AN01

ATC

lithium; oral

3.4

13.8

198

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

+∞

13.6

105

Kela drug reimbursment

Adrenal cortical hypofunction

+∞

13.6

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

13.5

147

711

H02AA02

ATC

fludrocortisone; oral

16.3

13.5

H53.4

ICD-10 Finland

Visual field defects

4.8

13.4

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

13.0

118

525

121

Kela drug reimbursment

Severe hypofunction of sexual glands

4.8

12.9

N05AA01

ATC

chlorpromazine; systemic, rectal

5.5

12.9

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.5

12.6

2592A

ICD-9 Finland

Other endocrine disorders, Carcinoid syndrome

+∞

12.5

106

Kela drug reimbursment

Hypoparathyroidism

+∞

12.5

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

+∞

12.5

2599X

ICD-9 Finland

Other endocrine disorders, Unspecified endocrine disorder

+∞

12.5

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

+∞

12.5

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

12.5

297

1897

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

12.4

702

5486

A06AD11

ATC

lactulose; oral

1.9

12.4

177

959

N05BA01

ATC

diazepam; systemic, rectal

1.8

12.2

203

1158

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.3

12.1

T99

ICPC

Endocr/metab/nutrit disease other

5.3

12.1

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

11.9

206

1191

XF404

NOMESCO Finland

Ambulatory ECG

2.2

11.9

127

610

R42

ICD-10 Finland

Dizziness and giddiness

1.6

11.8

304

1980

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.3

11.6

181

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

65.4

11.6

R41.0

ICD-10 Finland

Disorientation, unspecified

4.2

11.5

105

301

Kela drug reimbursment

Growth hormone

+∞

11.5

25320

ICD-8 Finland

Diseases of pituitary gland, Chromophobe adenoma, pituitary

+∞

11.5

P29

ICPC

Psychological sympt/compl other

2.1

11.3

130

644

N03AE01

ATC

clonazepam; systemic

2.4

11.3

415

R55

ICD-10 Finland

Syncope and collapse

2.0

11.3

141

724

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

8.9

11.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

11.3

383

2673

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

11.2

173

960

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

11.2

277

1783

E29.1

ICD-10 Finland

Testicular hypofunction

17.1

11.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

11.2

338

2295

A02BC02

ATC

pantoprazole; systemic

1.4

11.0

978

8252

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

10.9

178

1007

N05AE04

ATC

ziprasidone; systemic

5.7

10.9

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.2

10.8

T73

ICPC

Neoplasm endocrine other/unspecified

21.6

10.7

A28

ICPC

Limited function/disability NOS

1.9

10.7

150

806

R06.0

ICD-10 Finland

Dyspnoea

1.6

10.5

334

2290

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

10.5

244

1544

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

110.6

10.4

M14.5*E22.0

ICD-10 Finland

Arthropathy associated with acromegaly

+∞

10.4

E23

ICD-10 Finland

Hypofunction and other disorders of pituitary gland

+∞

10.4

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

+∞

10.4

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

10.4

394

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

32.7

10.3

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

10.3

519

3930

N05AE03

ATC

sertindole; oral

8.8

10.3

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

5.8

10.3

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

10.2

388

2772

N05AC02

ATC

thioridazine; oral

3.5

10.0

130

N06AX21

ATC

duloxetine; oral

1.8

10.0

185

1094

J01DB01

ATC

cefalexin; oral

1.4

10.0

1404

12738

WX402

NOMESCO Finland

General anaesthesia

1.6

9.9

268

1766

H47.2

ICD-10 Finland

Optic atrophy

12.2

9.8

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

9.8

228

L02AE04

ATC

triptorelin; parenteral

10.7

9.8

N05AD01

ATC

haloperidol; systemic

3.1

9.8

166

ZXC95

NOMESCO Finland

Use of surgical navigator

5.1

9.6

F82

ICD-10 Finland

Specific developmental disorder of motor function

11.4

9.6

N05AL01

ATC

sulpiride; systemic

4.7

9.5

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

9.5

183

1094

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

9.5

332

2328

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

9.5

144

795

2370A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct

100.5

9.4

E34.35

ICD-10 Finland

Abnormal growth retardation

100.5

9.4

E34.31

ICD-10 Finland

Short stature, prenatal disorder

+∞

9.4

22620

ICD-8 Finland

Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)

+∞

9.4

186

Kela drug reimbursment

Growth retardation associated with renal failure (growth hormone)

+∞

9.4

N06AB05

ATC

paroxetine; oral

2.0

9.4

114

582

SPAT1263

SPAT

Sampling

1.4

9.3

700

5677

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

9.3

198

1221

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.7

9.2

103

N05AX13

ATC

paliperidone; systemic

7.3

9.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

9.1

203

1266

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.4

9.1

130

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

9.1

122

645

N05AF05

ATC

zuclopenthixol; systemic

4.6

9.1

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

9.0

211

L17

ICPC

Foot/toe symptom/complaint

1.5

8.9

368

2665

7834C

ICD-9 Finland

Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]

24.1

8.9

N06AB06

ATC

sertraline; oral

1.7

8.9

201

1262

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

8.9

138

771

AA400

NOMESCO Finland

Electroconvulsive therapy

4.8

8.9

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

4.1

8.9

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.5

8.9

281

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

8.8

211

1342

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

8.8

224

1452

N06AG02

ATC

moclobemide; oral

2.4

8.7

315

S10

ICPC

Boil/carbuncle

2.2

8.7

401

E28.3

ICD-10 Finland

Primary ovarian failure

50.2

8.7

SPAT1234

SPAT

Support of social functional capacity

2.4

8.7

297

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

8.7

403

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.7

8.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

8.6

292

2028

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.1

8.6

153

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

5.3

8.6

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.5

8.6

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

8.6

526

4111

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.6

8.6

105

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

8.5

119

638

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

90.5

8.4

E30.8

ICD-10 Finland

Other disorders of puberty

90.5

8.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

8.4

605

4854

SPAT1254

SPAT

Administration of medicine

1.6

8.4

211

1360

X05

ICPC

Menstruation absent/scanty

3.5

8.4

107

J01MA12

ATC

levofloxacin; systemic

1.6

8.4

226

1487

A11CC03

ATC

alfacalcidol; systemic

4.0

8.3

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

8.3

184

1144

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

+∞

8.3

E27.0

ICD-10 Finland

Other adrenocortical overactivity

+∞

8.3

E22

ICD-10 Finland

Hyperfunction of pituitary gland

+∞

8.3

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

+∞

8.3

H01AX01

ATC

pegvisomant; parenteral

+∞

8.3

2598X

ICD-9 Finland

Other endocrine disorders, Other specified endocrine disorders

+∞

8.3

D352, E220

ICD-10 Finland

+∞

8.3

-50

ICPC

Medication/prescr/renewal

2.5

8.3

253

C07AB07

ATC

bisoprolol; oral

1.4

8.3

519

4063

N91.2

ICD-10 Finland

Amenorrhoea, unspecified

5.3

8.3

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

8.6

8.3

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

8.3

134

758

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

8.2

241

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.9

8.1

164

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

8.1

365

F28

ICD-10 Finland

Other nonorganic psychotic disorders

8.2

8.1

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

8.1

389

N03AX16

ATC

pregabalin; oral

1.5

8.1

326

2347

F83

ICD-10 Finland

Mixed specific developmental disorders

6.8

8.1

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

3.0

8.1

158

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.4

8.0

275

P01

ICPC

Feeling anxious/nervous/tense

1.6

7.9

232

1556

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

7.9

184

A12AA04

ATC

calcium carbonate; oral

4.9

7.9

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

7.9

401

WX110

NOMESCO Finland

Local anesthesy

1.3

7.8

1196

10719

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

7.8

228

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

7.7

144

855

SPAT1240

SPAT

Therapeutic discussion

1.6

7.7

215

1426

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

5.3

7.7

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

4.6

7.7

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

7.5

7.7

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

7.7

274

1925

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

7.6

495

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.4

7.6

105

N05BE01

ATC

buspirone; oral

2.7

7.6

184

137

Kela drug reimbursment

Uraemia requiring dialysis

6.7

7.6

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

11.9

7.6

F22.0

ICD-10 Finland

Delusional disorder

3.6

7.6

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.6

7.6

N03AX14

ATC

levetiracetam; systemic

2.9

7.6

155

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.9

7.6

155

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

7.5

173

1089

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

7.5

124

706

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.3

7.5

299

UKC02

NOMESCO Finland

Cystoscopy

1.7

7.4

161

997

E26.0

ICD-10 Finland

Primary hyperaldosteronism

80.4

7.4

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

5.3

7.4

Z50.1

ICD-10 Finland

Other physical therapy

2.2

7.4

336

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

7.4

130

756

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

7.4

149

907

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

7.3

106

580

H05BX01

ATC

cinacalcet; oral

+∞

7.3

E34.30

ICD-10 Finland

Short stature NOS

+∞

7.3

E30.9

ICD-10 Finland

Disorder of puberty, unspecified

+∞

7.3

E22.8

ICD-10 Finland

Other hyperfunction of pituitary gland

+∞

7.3

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

7.3

194

1272

N03AF01

ATC

carbamazepine; oral, rectal

2.2

7.3

331

SPAT1153

SPAT

Removal of sutures

1.4

7.3

407

3115

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

6.3

7.2

WX882

NOMESCO Finland

High dependency care

2.8

7.2

161

A02BC01

ATC

omeprazole; systemic

1.4

7.2

378

2858

N30.0

ICD-10 Finland

Acute cystitis

1.5

7.2

215

1449

B05DA

ATC

Isotonic solutions

7.3

7.2

Y28

ICPC

Limited function/disability (Y)

20.1

7.1

E86

ICD-10 Finland

Volume depletion

3.4

7.1

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.6

7.1

207

1388

P98

ICPC

Psychosis NOS/other

5.6

7.1

N02AA05

ATC

oxycodone; systemic

1.7

7.0

149

922

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

7.0

114

648

P99

ICPC

Psychological disorders other

2.4

6.9

240

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

6.9

178

1155

O92.6

ICD-10 Finland

Galactorrhoea

13.8

6.9

SPAT1243

SPAT

Psychiatric/psychological examination

2.2

6.9

294

S18

ICPC

Laceration/cut

1.3

6.9

554

4495

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.0

6.9

126

A01

ICPC

Pain general/multiple sites

1.8

6.8

111

630

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

6.8

447

L28

ICPC

Limited function/disability (L)

1.6

6.8

172

1112

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

6.8

156

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.3

6.8

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

6.8

388

2979

D12

ICPC

Constipation

2.7

6.8

167

E21.2

ICD-10 Finland

Other hyperparathyroidism

40.2

6.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

6.7

185

1219

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

6.7

135

821

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.5

6.7

211

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

6.7

143

885

N05AF01

ATC

flupentixol; systemic

3.2

6.7

100

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

7.2

6.7

A27

ICPC

Fear of other disease NOS

2.2

6.7

304

A46

ICD-10 Finland

Erysipelas

1.7

6.7

146

910

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

6.7

119

698

P85

ICPC

Mental retardation

22.6

6.7

TLW00

NOMESCO Finland

Insemination

2.6

6.7

176

A55

ICPC

General and Unspecified, Local injection/infiltration

4.9

6.7

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

5.9

6.6

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.5

6.6

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.5

6.6

G03GA01

ATC

chorionic gonadotrophin; parenteral

1.9

6.6

483

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

6.5

118

696

F45.0

ICD-10 Finland

Somatization disorder

6.9

6.5

SPAT1216

SPAT

Assessment of functional ability

1.6

6.5

166

1076

N03AX12

ATC

gabapentin; oral

1.5

6.5

210

1439

N03AX11

ATC

topiramate; oral

2.4

6.4

222

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

6.4

120

711

D35.30

ICD-10 Finland

Craniopharyngoma

70.1

6.4

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

6.4

161

127

Kela drug reimbursment

Transplant complication

3.8

6.4

X21

ICPC

Breast sympt/compl female other

2.5

6.4

187

U07

ICPC

Urine symptom/complaint other

2.0

6.3

375

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

6.6

6.3

C03DA01

ATC

spironolactone; oral

1.8

6.3

105

601

N06AA09

ATC

amitriptyline; systemic

1.7

6.3

124

747

A06AC51

ATC

ispaghula, combinations; systemic

2.0

6.3

362

N91.5

ICD-10 Finland

Oligomenorrhoea, unspecified

5.5

6.3

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.5

6.3

X78

ICD-10 Finland

Intentional self-harm by sharp object

4.6

6.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

6.3

112

660

2536X

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other disorders of neurohypophysis

+∞

6.3

E34.45

ICD-10 Finland

Abnormal growth increase

+∞

6.3

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

+∞

6.3

A12AA06

ATC

calcium lactate gluconate; oral

+∞

6.3

25301

ICD-8 Finland

Diseases of pituitary gland, Gigantismus hypophysarius et hyperpituitarismus alius

+∞

6.3

BBA20

NOMESCO Finland

Exploration of parathyroid gland

+∞

6.3

E220, D352

ICD-10 Finland

+∞

6.3

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

6.2

191

1296

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.2

447

3557

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.1

6.2

101

X07

ICPC

Menstruation irregular/frequent

2.8

6.2

135

N06AB10

ATC

escitalopram; oral

1.4

6.2

352

2695

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

6.3

6.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

6.1

109

641

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

7.7

6.1

R33

ICD-10 Finland

Retention of urine

2.0

6.1

366

P28

ICPC

Limited function/disability (P)

4.0

6.1

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

6.1

291

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

6.1

245

1763

XA800

NOMESCO Finland

Neuropsychological investigation

2.2

6.0

283

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

6.0

176

1179

M05BX04

ATC

denosumab; parenteral

2.5

6.0

190

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(43055514) Macroprolactin [Presence] in Serum or Plasma

316

85.04

307.65

2.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

820

914

14.47

307.65

5.5

1.3

mu/l

630.3

292.5

9.40

790

817

(3036481) Cortisol [Moles/volume] in Serum or Plasma

833

1455

9.07

307.65

4.0

1.8

nmol/l

371.9

379.4

0.51

795

1340

(3009214) Lutropin [Units/volume] in Serum or Plasma

437

549

9.89

307.65

2.0

1.3

u/l

8.1

10.5

2.58

360

431

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

464

64.58

307.65

3.8

1.4

nmol/l

20.3

21.1

0.38

454

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

275

273

11.51

249.83

4.6

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

200

145

15.21

220.31

1.7

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

46.28

164.51

2.9

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

357

784

5.32

156.67

4.7

1.8

nmol/l

9.9

12.5

5.78

330

694

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

227

395

6.35

127.03

1.5

1.3

nmol/l

0.3

0.5

2.30

169

321

(3008295) Osmolality of Serum or Plasma

119

129

9.74

100.08

2.4

1.4

mosm/kgh2o

276.5

282.3

1.36

103

100

(3023323) Follitropin [Units/volume] in Serum or Plasma

400

1348

3.46

95.90

1.9

1.3

iu/l

16.6

26.4

8.62

329

1140

(3003181) Sodium [Moles/volume] in Urine

132

184

7.61

90.50

2.5

1.3

mmol/l

79.6

65.4

2.07

114

160

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

135

224

6.39

78.57

2.9

1.5

pmol/l

155.3

205.0

3.34

129

210

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1057

6740

2.20

64.27

8.5

5.8

mmol/l

1.2

0.74

889

5729

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

975

6043

2.19

63.45

7.7

5.3

mmol/l

1.2

0.96

908

5503

(3018418) pH of Serum or Plasma

714

3907

2.28

63.22

5.0

3.3

7.4

0.24

163

720

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

305

1135

2.99

60.13

2.9

3.2

pmol/l

4.4

4.6

3.61

283

1016

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1686

13457

2.57

53.88

6.7

4.0

pmol/l

14.7

14.4

4.07

1617

12494

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

7.88

53.30

1.6

1.2

umol/l

5.4

5.3

0.07

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

137

365

3.95

45.47

1.9

1.4

u/l

14.2

24.2

4.49

124

309

(3003458) Phosphate [Moles/volume] in Serum or Plasma

340

1579

2.39

42.08

6.8

5.7

mmol/l

1.0

1.1

1.62

320

1476

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

7.67

36.16

2.0

1.4

nmol/l

1.7

1.8

0.08

(3001556) Androgen free Index in Serum or Plasma

18.92

35.27

1.4

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1155

8622

1.80

35.22

6.3

4.3

mmol/l

6.4

6.5

0.48

1083

7899

(3026782) Osmolality of Urine

477

2739

1.97

33.61

3.8

2.5

mosm/kgh2o

522.6

547.9

1.48

417

2339

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1784

15526

2.33

32.03

7.1

4.6

mu/l

1.7

2.0

1.66

1708

14579

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1438

11658

1.82

31.21

8.0

6.7

u/l

76.1

75.1

0.43

1370

10999

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

911

6518

1.73

30.62

2.9

2.2

nmol/l

75.2

74.7

0.20

849

5994

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

5.80

29.97

1.4

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

834

5851

1.73

29.89

4.9

4.5

g/l

35.7

36.4

2.79

768

5461

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

10.15

29.20

1.4

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

699

4716

1.74

28.49

3.5

3.1

mmol/l

2.3

0.16

629

4212

(3019550) Sodium [Moles/volume] in Serum or Plasma

1833

16310

2.41

28.28

20.3

11.8

mmol/l

139.2

139.6

6.19

1796

15868

(3023103) Potassium [Moles/volume] in Serum or Plasma

1833

16368

2.37

27.03

20.2

11.8

mmol/l

3.9

0.45

1794

15886

(42870588) Differential panel, method unspecified - Blood

745

5186

1.69

26.66

6.8

5.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

189

839

2.38

25.34

4.7

3.3

ng/l

89.4

72.7

0.85

162

754

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

591

3953

1.70

24.02

3.2

2.1

u/l

172.0

185.6

0.20

565

3755

(3013650) Neutrophils [#/volume] in Blood by Automated count

1171

9308

1.62

23.74

12.4

8.7

e9/l

4.1

4.0

1.39

1046

8199

(3012095) Magnesium [Moles/volume] in Serum or Plasma

353

2046

1.88

23.30

4.1

3.6

mmol/l

0.8

0.16

334

1916

(3013707) Erythrocyte sedimentation rate by Westergren method

1414

11839

1.66

22.67

4.4

3.8

mm/h

11.6

10.3

3.06

1334

11072

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

11.03

22.46

1.7

1.3

nmol/l

5.8

3.7

1.34

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

209

1035

2.14

21.46

4.7

2.8

mmol/l

1.2

0.32

186

885

(3003396) Base excess in Arterial blood by calculation

243

1295

2.00

20.44

8.2

8.3

mmol/l

1.2

1.1

0.11

192

1011

(3002030) Lymphocytes/100 leukocytes in Blood

1015

7976

1.55

20.22

7.5

5.9

29.0

29.2

0.29

958

7494

(3018010) Neutrophils/100 leukocytes in Blood

1003

7874

1.55

19.98

7.1

5.7

56.7

56.6

0.21

951

7417

(3006504) Eosinophils/100 leukocytes in Blood

978

7636

1.55

19.97

7.5

5.9

2.7

2.8

0.59

920

7138

(3019069) Monocytes/100 leukocytes in Blood

983

7691

1.54

19.83

7.8

6.1

8.3

8.2

0.71

931

7250

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

242

1302

1.98

19.78

8.3

kpa

5.2

5.1

0.51

225

1246

(3027801) Oxygen [Partial pressure] in Arterial blood

242

1303

1.97

19.74

8.3

8.2

kpa

13.3

12.9

0.44

224

1248

(3022096) Basophils/100 leukocytes in Blood

946

7364

1.54

19.37

7.5

5.9

0.7

0.12

892

6903

(3004789) Transferrin [Mass/volume] in Serum or Plasma

327

1970

1.79

18.74

2.6

2.2

g/l

2.4

0.12

297

1837

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

550

3808

1.61

18.71

2.5

2.1

mg/l

2.7

2.8

0.54

466

3282

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

744

5538

1.55

18.43

2.0

1.8

pmol/l

100.5

97.5

0.87

383

2953

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

642

4627

1.57

18.34

2.9

2.4

u/l

53.7

55.9

0.63

590

4288

(3021589) Normoblasts [#/volume] in Blood

930

7270

1.52

18.31

12.0

8.2

e9/l

0.0

0.43

792

5956

(3013115) Eosinophils [#/volume] in Blood

1051

8443

1.51

18.09

7.8

6.1

e9/l

0.2

1.11

939

7552

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1039

8331

1.51

18.02

3.3

2.8

ug/l

95.3

86.8

0.42

957

7842

(3019198) Lymphocytes [#/volume] in Blood

1046

8415

1.51

17.74

7.4

5.8

e9/l

1.9

2.0

0.94

938

7554

(3006315) Basophils [#/volume] in Blood

1019

8155

1.51

17.72

7.3

5.9

e9/l

0.0

0.30

899

7156

(1616796) Gas panel - Central venous blood

244

3.11

17.71

4.8

2.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

134

599

2.33

17.62

10.3

10.6

mmol/l

24.2

24.3

0.23

128

571

(3032080) INR in Blood by Coagulation assay

684

5042

1.54

17.49

7.6

6.9

inr

1.1

0.06

238

1578

(3019309) Folate [Moles/volume] in Red Blood Cells

353

2217

1.72

17.39

1.9

1.6

nmol/l

1198.9

1163.9

0.26

279

1714

(3001604) Monocytes [#/volume] in Blood

1012

8126

1.49

17.06

7.4

5.8

e9/l

0.6

0.5

1.10

895

7136

(3021960) Folate [Moles/volume] in Serum or Plasma

447

3016

1.62

16.63

1.5

nmol/l

20.2

20.7

0.33

390

2634

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

293

1779

1.76

16.20

2.8

2.3

21.6

23.6

1.41

254

1546

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1578

13988

1.60

16.09

5.7

4.6

mmol/mol

38.3

38.4

0.27

1505

13159

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

941

7531

1.47

15.61

6.3

5.6

umol/l

10.0

10.4

0.59

882

7117

(3002582) Erythrocytes [#/volume] in Urine

591

4310

1.53

15.49

4.0

2.9

e6/l

57.6

94.7

0.65

473

3249

(3026008) Bacteria identified in Urine by Culture

608

4467

1.52

15.37

3.6

2.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

191

1031

1.94

15.37

9.3

7.4

mmol/l

8.0

7.8

0.18

184

984

(3023368) Bacteria identified in Blood by Culture

481

3360

1.57

15.29

5.1

4.0

—

(3000991) Gas panel - Venous blood

192

1040

1.94

15.29

10.5

8.9

—

(3012501) Base excess in Blood by calculation

256

2.88

15.14

4.8

2.8

mmol/l

2.2

0.00

159

(3010421) pH of Blood

315

2.67

14.90

4.7

3.0

7.4

0.38

254

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

131

3.65

14.68

9.3

11.6

mmol/l

0.6

0.54

119

(3016502) Oxygen saturation in Arterial blood

203

1139

1.87

14.51

9.2

8.9

95.4

96.1

0.62

192

1099

(3030467) Casts [#/volume] in Urine by Automated count

542

3933

1.52

14.35

4.0

2.8

e6/l

0.3

0.4

0.82

423

2914

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1688

15327

1.63

14.28

4.7

3.8

mmol/l

5.7

0.13

1589

14224

(3002032) Base excess in Venous blood by calculation

204

1154

1.85

14.21

5.1

4.1

mmol/l

1.7

1.8

0.21

180

924

(3022948) Iron [Moles/volume] in Serum or Plasma

334

2175

1.64

14.12

2.7

2.2

umol/l

13.1

14.1

1.42

308

2024

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

155

3.35

13.99

1.3

1.2

pmol/l

375.0

332.5

0.29

116

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

429

2996

1.55

13.44

3.2

2.9

ng/l

816.0

989.5

0.78

365

2484

(3000850) Epithelial cells [#/volume] in Urine

426

2973

1.55

13.38

3.5

2.4

e6/l

6.8

7.9

1.01

383

2607

(3021447) Carbon dioxide [Partial pressure] in Venous blood

202

1161

1.82

13.35

5.1

4.1

kpa

5.9

5.8

0.83

197

1127

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

21.30

13.33

2.7

2.9

pmol/l

66.6

78.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1666

15147

1.59

13.25

15.2

9.7

ml/min/173m2

89.6

89.3

0.21

1453

12293

(3002173) Hemoglobin [Mass/volume] in Arterial blood

190

1076

1.85

13.17

9.6

9.0

g/l

121.4

121.7

0.05

182

1036

(36304419) Bacteria [Presence] in Urine

532

3913

1.49

12.99

4.0

2.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

244

2.76

12.95

7.0

5.8

umol/l

388.9

376.9

0.29

210

(3018677) aPTT in Platelet poor plasma by Coagulation assay

312

2060

1.61

12.37

1.9

2.3

29.4

29.6

0.24

301

1990

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

695

5421

1.43

12.36

3.4

3.1

u/l

31.5

29.7

0.35

660

5170

(3027945) Reticulocytes/100 erythrocytes in Blood

217

1311

1.73

12.08

3.3

2.8

1.8

1.7

0.61

183

1186

(40767503) Oxygen content in Capillary blood by calculation

232

2.68

11.37

3.0

2.0

17.6

16.3

0.81

111

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

221

1370

1.69

11.19

2.5

2.2

u/l

5535.8

6152.1

0.12

538

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1321

11621

1.40

11.10

3.7

2.9

u/l

41.7

38.8

0.67

1264

11073

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

216

1334

1.69

11.08

3.7

2.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

339

2349

1.53

10.80

2.8

2.7

mmol/l

2.4

1.03

286

2039

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

631

4936

1.41

10.70

4.6

3.0

ng/l

34.0

44.7

0.42

383

2687

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

8.29

10.62

1.5

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

519

3927

1.43

10.60

1.6

mmol/l

1.5

1.4

1.43

456

3379

(3020630) Protein [Mass/volume] in Serum or Plasma

156

890

1.82

10.55

3.0

2.7

g/l

66.4

67.1

0.60

142

833

(3033658) Prothrombin time (PT) actual/Normal

498

3743

1.44

10.54

4.5

3.6

95.3

94.5

0.28

489

3629

(3009508) Creatinine [Moles/volume] in Urine

537

4095

1.42

10.49

3.5

3.2

mmol/l

8.1

7.8

0.50

461

3528

(3013512) EKG study

490

3677

1.44

10.45

3.7

3.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1784

16694

1.61

10.25

17.1

11.2

mg/l

20.4

21.0

0.31

1435

12850

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

389

2.21

10.23

2.6

2.4

ug/l

286.3

355.1

0.20

351

(40758558) Short blood count panel - Blood

528

4034

1.42

10.15

8.9

6.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

232

1494

1.63

10.11

8.9

7.0

mmol/l

103.8

104.6

1.41

227

1461

(40761536) Microorganisms panel - Urine sediment

223

1424

1.64

10.05

4.5

3.5

—

(3023520) Reticulocytes [#/volume] in Blood

157

911

1.78

10.04

2.9

2.8

e9/l

73.9

71.8

0.30

106

682

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

218

1398

1.63

9.65

2.1

1.7

—

(3044889) 12 lead EKG panel

1184

10346

1.35

9.64

3.9

3.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

302

2089

1.52

9.63

2.3

1.8

—

(40768797) Stomach Pathology biopsy report

296

2051

1.52

9.35

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1270

11243

1.35

9.33

5.4

3.9

—

(3017181) Myelocytes/100 leukocytes in Blood

198

1250

1.65

9.33

5.0

4.3

1.1

1.0

0.22

324

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

219

1419

1.61

9.29

2.2

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

393

2.13

9.20

7.0

5.1

mg/l

1.5

1.3

1.04

368

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

216

2.54

9.16

4.3

2.3

—

(3018095) Leukocytes [#/volume] in Urine

662

5327

1.36

9.14

4.8

3.3

e6/l

79.5

74.9

0.08

498

3545

(4035726)

189

1189

1.65

9.03

1.4

—

(3042936) Bacteria identified in Isolate by Culture

284

1968

1.52

8.96

2.3

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

166

2.75

8.95

1.2

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

310

2192

1.49

8.86

3.3

2.6

e6/l

4.0

3.5

0.33

184

1146

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.50

8.84

2.8

2.4

umol/l

14.6

16.1

0.23

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

151

2.82

8.77

1.6

1.2

nmol/l

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1211

10701

1.33

8.68

5.7

3.9

e6/l

259.0

1422.5

1.25

125

(3044290) Cell count panel - Cerebral spinal fluid

337

2.18

8.59

1.4

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

125

713

1.80

8.49

3.0

2.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

187

1193

1.63

8.45

5.2

4.3

0.1

1.59

295

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

172

2.65

8.38

1.6

1.2

nmol/l

0.5

0.6

0.13

163

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1846

17562

1.63

8.19

11.7

8.9

u/l

26.2

25.2

1.38

1794

17039

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

323

2347

1.45

7.99

3.1

2.4

e6/l

1.2

1.0

0.33

199

1287

(3035350) Ketones [Presence] in Urine by Test strip

938

8053

1.31

7.98

4.2

3.2

estimate

0.0

0.80

214

1513

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

380

2847

1.41

7.94

1.6

pmol/l

24299531.5

41063821.6

0.27

321

2445

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.41

7.80

1.9

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

946

8147

1.30

7.80

4.3

3.3

estimate

0.0

1.06

213

1502

(3023511) Choriogonadotropin [Units/volume] in Urine

130

770

1.74

7.78

1.5

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

139

2.77

7.72

1.6

1.7

—

(3019060) Gas panel - Arterial blood

124

727

1.75

7.70

4.7

5.6

—

(40761511) CBC panel - Blood by Automated count

1851

17661

1.61

7.62

16.5

10.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

936

8068

1.30

7.59

5.9

4.4

estimate

0.0

0.72

216

1546

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

369

2.04

7.54

1.3

1.6

e6/l

205.5

20.4

0.49

284

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

369

2.04

7.54

1.4

1.7

e6/l

1076.7

940.2

0.04

297

(3052851) Hemolysis interference index of Serum or Plasma

418

1.98

7.51

2.6

3.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

160

2.60

7.37

1.6

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

114

664

1.76

7.25

5.3

4.5

mmol/l

24.2

24.0

0.47

107

613

(3002385) Erythrocyte distribution width [Ratio]

1563

14487

1.36

7.24

21.9

13.6

13.5

0.86

1541

14198

(3041096) Erythrocytes [Presence] in Urine by Automated

573

4645

1.33

7.19

3.9

2.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

371

2.00

7.08

1.7

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

129

784

1.69

7.06

4.9

3.4

mmol/l

1.5

1.6

0.17

583

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

131

801

1.68

7.01

1.6

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

181

1199

1.56

6.99

3.0

2.7

g/l

10.4

0.01

155

1100

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

105

608

1.77

6.83

12.0

11.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

473

3758

1.34

6.76

1.6

1.4

g/l

2.4

2.2

0.35

273

2348

(3022145) Colonoscopy Study observation

230

1615

1.48

6.76

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

132

818

1.66

6.72

5.0

3.4

kpa

5.1

0.11

123

770

(3023183) Ammonium ion [Moles/volume] in Plasma

270

2.14

6.67

2.1

3.1

umol/l

31.1

32.1

0.16

235

(3009343) pH of Capillary blood

131

812

1.66

6.66

5.1

3.4

7.4

0.05

(3007461) Platelets [#/volume] in Blood

1943

18850

1.94

6.66

27.0

16.6

e9/l

265.7

261.1

2.37

1911

18448

(3002179) Metamyelocytes/100 leukocytes in Blood

173

1148

1.55

6.64

5.1

4.1

0.6

0.26

238

(3023410) Appearance of Cerebral spinal fluid

175

2.43

6.62

1.2

2.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

540

4385

1.32

6.61

1.4

1.3

u/ml

1.1

1.6

0.93

134

1184

(3015235) Bicarbonate [Moles/volume] in Capillary blood

292

2.09

6.56

3.8

2.4

mmol/l

24.7

24.9

0.14

261

(3008152) Bicarbonate [Moles/volume] in Arterial blood

116

702

1.69

6.47

7.1

7.7

mmol/l

25.4

24.5

1.85

104

655

(3024731) MCV [Entitic volume]

1943

18862

1.92

6.46

26.9

16.5

90.0

90.3

1.87

1930

18656

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

324

2442

1.39

6.46

4.0

3.3

ng/l

631.6

374.1

0.35

205

1547

(3025159) Blasts/100 leukocytes in Blood

169

1123

1.55

6.45

5.4

4.4

0.0

0.8

0.88

244

(3035941) MCH [Entitic mass]

1943

18864

1.91

6.43

26.9

16.5

30.0

30.1

2.82

1929

18655

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

181

1223

1.53

6.40

2.2

g/l

0.2

0.19

162

1146

(40768804) Tissue Pathology biopsy report

774

6612

1.28

6.38

2.0

—

(4198724)

102

2.87

6.37

2.3

1.9

—

(3026361) Erythrocytes [#/volume] in Blood

1943

18868

1.91

6.36

27.0

16.6

e12/l

4.5

1.66

1909

18434

(3007853) Bacteria identified in Skin by Aerobe culture

248

1790

1.44

6.31

2.1

1.6

—

(3010813) Leukocytes [#/volume] in Blood

1943

18871

1.90

6.31

27.0

16.6

e9/l

6.7

0.07

1909

18429

(3000963) Hemoglobin [Mass/volume] in Blood

1943

18877

1.89

6.21

27.2

16.7

g/l

133.5

134.9

4.94

1930

18665

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

476

1.82

6.20

1.5

2.0

iu/l

1.9

4.6

7.20

186

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

147

955

1.58

6.19

1.8

1.7

—

(3021901) Oxygen saturation in Capillary blood

188

2.32

6.12

4.0

2.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

318

2410

1.38

6.12

1.8

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

182

2.34

6.10

1.7

1.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

4.13

6.09

1.8

2.9

ug/l

73.6

96.5

0.28

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

191

1322

1.49

6.03

4.4

u/l

235.7

247.8

0.42

177

1252

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1622

15243

1.33

5.93

3.9

3.4

mmol/l

1.3

1.2

2.52

1537

14331

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

210

2.22

5.93

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

136

2.53

5.87

1.9

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

259

2.07

5.77

1.3

1.7

g/l

0.6

0.8

0.47

195

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

126

2.56

5.71

1.3

1.2

u/l

62.5

72.4

0.28

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

736

6320

1.26

5.63

4.5

3.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1699

16113

1.35

5.56

4.7

4.0

mmol/l

2.8

2.9

1.00

1616

15145

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1681

15922

1.34

5.51

4.4

3.7

mmol/l

4.7

4.8

2.61

1602

15086

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

327

1.92

5.48

2.4

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

211

1521

1.43

5.41

1.2

iu/ml

112.1

158.0

0.95

578

(3029937) Albumin [Presence] in Urine by Test strip

515

4253

1.28

5.40

4.6

3.6

estimate

0.0

0.20

215

1522

(3028707) Methadone [Presence] in Urine by Screen method

475

1.76

5.39

3.6

2.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

226

2.11

5.36

2.5

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

127

830

1.57

5.25

2.9

2.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

464

1.75

5.24

1.6

2.0

g/l

1.5

0.18

409

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

297

1.95

5.23

8.8

6.0

iu/ml

495.6

308.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

326

1.90

5.20

2.2

1.6

—

(3036603) Volume of Urine

2.90

5.19

1.5

2031.8

2171.5

—

(36660697) Celiac disease serology panel - Serum

215

1568

1.42

5.17

1.2

—

(3000330) Specific gravity of Urine by Test strip

108

684

1.61

5.10

3.6

3.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

401

1.80

5.10

1.8

2.2

mg/l

10.6

10.7

0.05

377

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.98

4.99

1.6

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

282

1.94

4.94

4.1

3.6

mg/l

31.2

68.3

0.99

232

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

227

2.05

4.93

1.8

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

334

1.85

4.85

1.6

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1668

15847

1.31

4.85

4.3

3.7

mmol/l

1.5

5.15

1589

14931

(3020191) Ethanol [Moles/volume] in Serum or Plasma

137

2.36

4.84

1.4

1.7

promille

1.1

1.3

0.27

111

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

9.03

4.78

1.0

1.2

ng/l

88.7

118.9

—

(3012516) Albumin [Mass/volume] in Urine

423

3458

1.28

4.74

3.4

3.3

mg/l

494.1

345.1

0.23

269

2184

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

428

1.73

4.65

2.6

2.0

ug/l

1.1

1.8

0.42

377

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

282

1.90

4.62

4.2

3.6

mg/l

24.6

39.0

0.73

232

(40760892) CBC W Ordered Manual Differential panel - Blood

479

3988

1.26

4.61

5.2

4.2

—

(3044640) Blood type and Crossmatch panel - Blood

577

4912

1.25

4.57

2.8

2.2

—

(3030313) Adrenal Ab [Titer] in Serum

8.21

4.56

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

113

745

1.55

4.53

4.0

2.8

—

(3011412) CD3 cells [#/volume] in Blood

148

2.25

4.51

3.0

2.8

e9/l

1.3

1.1

0.32

(3024139) IgG subclass 3 [Mass/volume] in Serum

161

2.19

4.50

1.3

g/l

0.4

0.23

108

(3028192) IgG subclass 2 [Mass/volume] in Serum

161

2.19

4.50

1.3

g/l

2.2

2.9

2.76

109

(3000494) Fungus identified in Specimen by Culture

239

1820

1.36

4.44

1.8

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

162

2.18

4.44

1.3

g/l

6.2

6.8

0.45

111

(3027008) Opiates [Presence] in Urine

150

1055

1.46

4.42

2.9

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.63

4.40

2.3

3.3

umol/l

202.2

151.3

0.17

(3028300) Cannabinoids [Presence] in Urine

150

1057

1.45

4.38

3.0

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

149

1049

1.45

4.37

3.0

2.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.52

4.33

1.1

—

(4062490)

164

2.15

4.32

1.3

—

(40768443) Skin Pathology biopsy report

618

1.58

4.29

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

100

651

1.56

4.26

1.5

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

214

1.98

4.17

1.4

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

228

1741

1.35

4.17

2.7

2.8

umol/l

7.3

6.9

0.14

183

1478

(3040151) Glucose [Moles/volume] in Capillary blood

134

2.26

4.16

8.1

5.1

mmol/l

8.2

6.7

0.54

111

(3025941) Bacteria identified in Stool by Culture

146

1035

1.44

4.14

1.3

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

194

2.03

4.14

4.9

3.1

1.0

1.4

0.50

157

(3048689) Calprotectin [Mass/mass] in Stool

299

2380

1.30

4.09

1.9

2.4

ug/g

88.0

103.9

0.78

232

1889

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

125

862

1.48

4.09

3.0

2.8

ng/l

144.9

164.4

0.28

112

770

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

346

1.76

4.08

2.9

3.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

461

1.65

4.05

4.7

6.3

1.6

0.01

429

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

291

2317

1.30

3.97

1.9

1.7

1.5

1.4

0.59

264

2075

(3016879) Cocaine [Presence] in Urine

137

968

1.45

3.96

3.0

2.1

—

(3042631) Mycobacterium sp identified in Specimen

145

2.16

3.87

3.0

2.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

435

3649

1.25

3.86

2.5

2.3

umol/l

324.6

4564.6

9.47

377

3191

(3000570) Elastase.pancreatic [Mass/mass] in Stool

406

1.67

3.84

1.4

ug/g

260.2

301.5

0.97

209

(3022313) Gas panel - Capillary blood

611

1.55

3.83

5.3

3.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

130

918

1.44

3.78

6.0

2.2

ug/l

6.4

6.5

0.03

111

816

(3020682) Albumin/Creatinine [Ratio] in Urine

433

3638

1.24

3.78

4.1

4.0

mg/mmol

6.2

9.0

1.23

277

2325

(3037756) Immunofixation for Serum or Plasma

208

1.94

3.78

2.0

1.7

—

(3027944) Amphetamines [Presence] in Urine

144

1038

1.42

3.75

2.9

2.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

209

1.93

3.73

5.1

3.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

195

1.97

3.73

1.3

—

(3042517) Benzodiazepines panel - Urine

4.02

3.70

2.3

2.2

—

(3019225) pH of Specimen

172

1282

1.37

3.69

4.8

3.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

122

2.23

3.67

1.3

2.1

32.0

32.1

0.05

122

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

103

2.35

3.67

2.4

2.3

—

(3020891) Body temperature

443

1.62

3.65

5.2

4.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

328

1.73

3.64

3.0

3.9

u/ml

0.4

0.12

177

(3021879) Hepatitis B virus core Ab [Presence] in Serum

202

1548

1.34

3.62

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.26

3.62

1.1

116.7

88.6

2.57

(3028026) IgM [Mass/volume] in Serum or Plasma

130

929

1.43

3.56

1.7

1.8

g/l

1.4

0.13

118

858

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

444

3764

1.23

3.55

1.8

mg/l

1.4

1.0

0.75

337

2785

(3043409) Potassium [Moles/volume] in Arterial blood

346

1.70

3.54

4.2

4.1

mmol/l

3.8

0.24

323

(21494814) CD8 cells/100 lymphocytes in Specimen

3.06

3.53

2.7

2.1

—

(3024928) Oxygen saturation in Venous blood

272

1.78

3.51

3.1

3.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

10.02

3.50

1.0

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

101

693

1.48

3.43

1.9

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

289

1.75

3.43

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

289

1.75

3.43

1.2

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

167

1.99

3.39

1.3

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

159

1187

1.37

3.39

2.4

au/ml

39.9

20.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

460

1.59

3.38

4.7

6.4

0.9

0.25

429

(4306422)

283

1.75

3.37

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

3.11

3.37

5.1

4.0

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

306

1.72

3.35

3.7

3.5

e9/l

4.5

4.1

0.63

306

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

369

1.65

3.29

3.0

2.0

g/l

9.7

10.4

0.57

329

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

316

1.70

3.27

4.1

3.7

59.3

57.2

0.65

316

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

401

1.62

3.27

2.9

1.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

401

1.62

3.27

2.9

1.9

g/l

3.7

0.00

299

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

401

1.62

3.27

2.9

1.9

g/l

7.3

0.15

320

(3033705) Calcium.ionized [Moles/volume] in Venous blood

142

2.06

3.27

3.5

2.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

109

2.22

3.25

1.6

1.4

33.0

33.8

0.03

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

379

1.63

3.23

3.0

2.0

g/l

3.0

3.1

0.41

309

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.17

3.21

4.1

3.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

655

1.47

3.17

1.8

2.1

u/l

40.5

39.2

0.30

603

(3037522) Nuclear Ab [Titer] in Serum

297

2439

1.26

3.16

1.4

titre

441.3

542.1

0.47

490

(3047181) Lactate [Moles/volume] in Blood

389

1.61

3.16

5.5

7.3

mmol/l

1.3

1.2

0.15

333

(1761482) Bacteria [#/volume] in Urine by Culture

304

1.70

3.16

5.2

4.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

312

1.68

3.15

3.0

2.0

g/l

0.0

0.50

296

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.42

3.14

1.3

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.52

3.11

6.0

5.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

145

2.01

3.10

6.3

3.7

—

(40768446) Kidney Pathology biopsy report

2.69

3.06

2.0

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

179

1384

1.32

3.05

17.7

18.5

inr

1.3

1.2

0.34

214

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

315

1.67

3.05

3.1

2.0

g/l

38.0

38.1

0.05

286

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.46

3.05

1.5

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.46

3.05

3.1

2.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

294

1.68

2.98

1.4

1.3

u/ml

4.4

4.0

0.14

133

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

114

2.12

2.94

2.5

2.3

9.5

12.4

1.18

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.60

2.87

2.4

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.60

2.87

2.4

1.4

—

(3049717) Cytology report of Urine Cyto stain

369

1.59

2.83

2.3

2.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

427

3686

1.20

2.80

2.9

2.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

434

1.54

2.79

1.1

1.3

titre

82.0

83.5

—

(4268621)

202

1.80

2.78

2.6

2.3

—

(21494755) Public health laboratory ask at order entry panel

181

2279

0.77

2.76

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

343

1.59

2.67

4.0

2.1

g/l

0.7

0.8

0.04

315

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.13

2.65

1.1

—

(3014271) Vancomycin [Susceptibility]

2.80

2.64

2.9

2.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

353

1.57

2.61

1.5

1.4

—

(3039000) Anion gap in Blood

261

1.66

2.55

6.2

9.1

mmol/l

10.7

11.4

0.54

235

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.16

2.55

3.0

4.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.16

2.55

3.0

4.7

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

101

2.09

2.53

3.4

3.0

—

(3018572) Chloride [Moles/volume] in Blood

262

1.66

2.52

6.2

9.0

mmol/l

104.2

105.5

0.57

236

(4010399)

134

1026

1.33

2.49

1.6

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

263

1.65

2.48

2.6

2.0

g/l

133.2

130.8

0.22

194

(3036489) Thrombin time

639

1.41

2.46

2.1

2.4

20.7

21.0

0.41

553

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.30

2.41

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

534

4756

1.17

2.41

2.1

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.01

2.40

1.7

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

190

1.75

2.38

1.4

1.5

mmol/l

10.6

11.9

0.38

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

146

1.86

2.37

1.9

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.26

2.37

6.8

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

378

1.52

2.37

1.4

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.15

2.35

2.1

1.5

u/l

7.3

4.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

717

1.37

2.29

1.3

u/ml

0.2

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.63

2.27

1.2

1.5

nmol/l

37.8

20.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.49

2.27

3.1

2.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.03

2.26

2.6

2.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

1.93

2.25

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

634

1.39

2.24

1.4

1.3

—

(3037121) Protein [Mass/volume] in Urine

492

1.44

2.21

2.9

3.5

g/l

0.1

0.3

3.01

197

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

328

1.54

2.20

1.5

1.4

u/ml

100.1

106.6

0.22

(3019150) Specific gravity of Urine by Refractometry

397

3478

1.18

2.19

4.4

3.5

kg/l

1.0

0.32

494

(3014051) Protein [Presence] in Urine by Test strip

361

1.51

2.18

1.8

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

663

1.37

2.18

2.4

2.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

177

1434

1.26

2.16

3.2

2.4

u/l

29.7

73.1

0.71

151

1225

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

202

1662

1.24

2.16

4.1

3.7

31.5

32.2

0.40

157

1204

(3024869) Neuronal Ab [Presence] in Serum

4.30

2.15

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.01

2.14

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

280

2387

1.20

2.11

4.7

4.4

ug/l

1.5

2.2

3.24

259

2138

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.21

2.11

2.4

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

548

1.40

2.10

5.8

3.9

mmol/l

24.6

24.8

0.15

521

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

292

1.55

2.09

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

153

1.78

2.08

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

293

1.55

2.06

1.2

1.1

—

(3002256) Pathology report gross observation

234

1968

1.21

2.03

1.2

—

(3004451) EKG impression Narrative

2.51

2.01

1.2

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

352

1.49

2.01

1.7

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.01

2.00

1.4

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

104

1.93

2.00

2.1

u/field

0.6

2.3

2.02

(3045142) Bone marrow Pathology biopsy report

133

1.81

1.99

1.5

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

2.29

1.97

1.6

2.4

e6/l

156.3

218.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

171

1.71

1.97

1.9

1.4

—

(3000012) Reticulocyte production index

2.36

1.95

1.1

1.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

2.36

1.95

1.1

1.2

u/l

13.7

11.7

0.34

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

236

1.58

1.88

1.9

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

238

0.46

1.87

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

205

1.62

1.86

1.9

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

817

7605

1.13

1.85

4.4

3.9

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.54

1.84

2.3

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.51

1.83

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

405

3604

1.15

1.82

2.4

2.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

230

1.58

1.82

1.8

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

183

1.65

1.82

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

108

1.86

1.81

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

367

3244

1.16

1.81

2.3

2.1

—

(3028433) Virus identified in Specimen by Culture

2.27

1.80

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1652

16066

1.16

1.78

19.1

12.1

39.4

39.9

1.56

1246

12831

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

430

1.41

1.76

1.3

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

139

1.74

1.75

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

170

1.66

1.74

2.1

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

323

1.47

1.72

1.8

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

158

1906

0.81

1.72

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

407

3639

1.15

1.72

4.2

3.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.14

1.71

4.7

3.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.01

1.69

1.1

u/ml

0.1

11.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

227

2639

0.84

1.67

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.16

1.66

5.5

7.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.16

1.66

2.0

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.16

1.66

1.5

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

252

1.52

1.66

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.59

1.66

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

157

1.66

1.6

51.1

56.4

0.21

104

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

142

1.70

1.64

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

302

1.47

1.63

1.2

1.1

—

(3045414) Leukocytes [Presence] in Urine

709

1.30

1.59

1.6

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

321

1.44

1.58

1.6

1.7

e6/l

12529.1

12607.2

0.00

235

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

149

1791

0.82

1.58

1.4

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.01

1.58

3.7

2.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

109

1355

0.79

1.58

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

682

0.71

1.58

1.3

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.04

1.54

1.2

u/l

11.8

24.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.28

1.53

1.1

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

100

1.81

1.53

1.5

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

1.52

1.6

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.87

1.50

1.2

mmol/l

5.1

6.6

1.60

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

2.01

1.48

1.2

u/l

61.7

92.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.37

1.45

2.9

2.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.51

1.45

1.4

1.2

74.4

56.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

1.43

1.5

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

118

1.70

1.41

3.2

2.6

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.26

1.40

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.26

1.40

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.26

1.40

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.26

1.40

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.42

1.39

1.3

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

330

2953

1.14

1.39

1.3

u/ml

4.2

10.0

1.98

127

1224

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

136

1132

1.22

1.38

2.8

2.2

ml/min/173m2

78.0

75.1

0.30

412

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

119

1.69

1.37

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.95

1.36

2.4

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.13

1.33

1.6

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

428

0.67

1.32

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

160

1.57

1.31

2.3

2.1

mg/l

27.0

22.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.50

1.30

1.0

1.2

—

(3047189) Immunofixation for 24 hour Urine

2.10

1.30

2.1

1.7

—

(3000285) Sodium [Moles/volume] in Blood

2.78

1.28

1.6

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.89

1.28

1.5

1.4

pmol/l

70.6

58.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.01

1.27

4.1

3.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.29

1.27

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

170

1.54

1.26

1.3

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.86

1.24

1.0

1.1

114.1

113.6

0.02

(3044242) Glucose [Moles/volume] in Arterial blood

1.97

1.22

1.3

3.1

—

(3024471) HLA-A [Type]

2.05

1.22

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

147

1250

1.19

1.22

1.4

1.3

u/ml

142.9

222.8

1.25

134

1155

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

297

1.39

1.20

1.4

1.2

u/ml

2.9

4.5

0.56

102

(3050129) First trimester maternal screen panel - Serum or Plasma

1168

0.81

1.20

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

181

1.50

1.18

2.0

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

183

1590

1.17

1.18

8.5

5.4

—

(3024932) HLA-DR beta [Type]

2.01

1.16

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

182

1.49

1.16

2.0

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

715

1.24

1.16

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.06

1.15

1.3

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

887

0.79

1.14

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

183

1.48

1.13

2.0

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

183

1.48

1.13

2.0

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

420

3865

1.11

1.12

1.8

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.97

1.11

1.8

2.4

—

56101.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

184

1.47

1.11

2.0

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

342

3117

1.12

1.09

1.3

iu/ml

38.0

27.0

0.51

102

963

(4024509)

120

1.59

1.08

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.87

1.07

1.1

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.87

1.07

1.1

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

780

0.79

1.07

1.6

1.7

—

(4027681)

137

1.54

1.05

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.96

1.03

1.7

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.96

1.03

1.8

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.96

1.03

1.7

1.1

—

(21494434) Karyotype in Bone marrow

1.64

1.03

1.3

—

(3017569) Oxygen content in Arterial blood

1.88

1.00

1.2

3.6

—

(3044927) Protein electrophoresis panel - Urine

107

1.59

0.99

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

123

1.55

0.99

1.6

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

123

1.55

0.99

1.0

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

115

1.57

0.99

1.3

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

103

867

1.20

0.99

1.3

miu/ml

218.6

230.4

0.11

456

(3043238) Trisomy 21 risk [Likelihood] in Fetus

793

0.80

0.98

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

181

1.44

0.98

2.0

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.95

0.97

1.1

1.2

60.9

45.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

116

1.56

0.96

5.8

3.1

58.6

53.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

116

1.56

0.96

1.1

ratio

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

878

0.81

0.96

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

199

1.41

0.95

1.5

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

2.23

0.93

1.7

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

286

1.34

0.93

3.0

2.5

ug/min

54.2

113.5

1.05

185

(3008536) Aspergillus sp Ab [Presence] in Serum

2.15

0.91

4.3

2.0

—

(3011648) Oxygen content in Venous blood

102

1.57

0.90

2.1

3.5

11.2

11.4

0.08

102

(40768800) Prostate Pathology biopsy report

127

0.55

0.88

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

111

1.54

0.87

1.1

—

(3048879) Bone marrow aspiration report

2.00

0.87

1.7

2.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

405

1.27

0.86

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.72

0.86

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.67

0.85

1.2

u/l

157.8

405.1

0.86

(3035880) pH of Pleural fluid

1.78

0.84

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

212

1914

1.12

0.83

3.8

3.9

23.6

21.1

1.33

804

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

112

0.53

0.83

2.0

1.3

—

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.74

0.82

1.8

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.88

0.81

1.2

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.88

0.81

1.5

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.88

0.81

1.5

2.6

—

(3017732) Neutrophils [#/volume] in Blood

133

1167

1.15

0.81

4.0

2.4

e9/l

3.8

4.1

0.82

101

981

(40768806) Pleura Pathology biopsy report

1.58

0.81

1.3

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

773

0.82

0.81

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

473

1.23

0.80

1.4

1.3

u/ml

14.5

9.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

116

1329

0.87

0.80

1.3

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.73

0.79

1.0

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

4.8

—

(3020650) Glucose [Presence] in Urine

1.67

0.78

1.1

1.5

—

(3005033) Fetal Nuchal fold Thickness US

770

0.83

0.78

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

1.63

0.78

1.1

1.4

nmol/l

131.3

137.6

0.18

(3013139) Helicobacter pylori Ag [Presence] in Stool

129

1135

1.15

0.77

1.1

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

494

1.22

0.77

2.0

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

107

1.50

0.76

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

132

1.44

0.76

3.1

2.8

e6/l

709.6

833.2

0.38

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.65

0.75

4.2

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.65

0.75

1.8

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.65

0.75

4.2

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.65

0.75

4.2

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.65

0.75

4.2

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.64

0.73

4.9

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.64

0.73

4.9

2.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

589

1.20

0.73

1.1

u/ml

7.2

4.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

490

0.79

0.72

1.3

1.4

pmol/l

52.1

137.3

1.78

478

(3017509) Phencyclidine [Presence] in Urine

2.00

0.72

3.6

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.61

0.72

4.9

2.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.93

0.70

1.6

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1017

0.86

0.70

1.4

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

126

1.43

0.70

1.2

1.3

—

(3051651) Icteric interference index of Serum or Plasma

101

1.49

0.70

3.1

3.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.53

0.68

2.8

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

127

1.42

0.68

1.2

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

111

978

1.14

0.67

1.9

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.55

0.67

2.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

136

1.40

0.66

2.7

3.3

—

(4094501)

357

1.24

0.66

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

154

1.37

0.65

2.0

2.5

—

(40761535) Cells panel - Urine sediment

126

1124

1.13

0.64

4.5

3.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

190

1.32

0.62

1.4

1.2

—

(3021788) Differential panel - Synovial fluid

252

1.27

0.62

1.7

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

102

0.59

0.62

1.2

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

388

1.22

0.62

1.3

u/ml

275.9

246.9

0.26

238

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

770

0.85

0.61

1.8

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1362

13357

1.06

0.61

3.8

3.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

555

1.18

0.60

2.4

1.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.57

0.60

1.0

1.1

—

69.1

—

(3045424) Erythrocytes [Presence] in Urine

254

1.26

0.59

1.2

1.5

—

(1002224) Polysomnography panel

790

1.15

0.59

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

219

1.28

0.58

1.4

1.3

—

47.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

282

1.25

0.58

1.1

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

1.39

0.58

1.2

1.1

u/l

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

320

0.78

0.57

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.56

1.7

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.58

0.56

1.2

2.1

ug/l

20.7

114.5

—

(44790049)

185

1.30

0.56

1.7

1.5

—

(44790047)

185

1.30

0.56

1.7

1.5

—

(44806118)

185

1.30

0.56

1.7

1.5

—

(44790048)

185

1.30

0.56

1.7

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.55

1.0

—

4.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.54

0.55

1.1

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

154

1405

1.10

0.55

2.7

2.8

ug/l

0.6

0.7

2.15

101

833

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

128

1157

1.11

0.54

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

122

0.65

0.54

1.3

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

123

0.65

0.54

1.9

1.3

g/l

0.9

—

123

(3012441) Differential panel - Pleural fluid

1.47

0.54

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.50

0.54

1.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

125

1.36

0.53

3.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

125

1.36

0.53

3.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

125

1.36

0.53

3.4

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.43

0.52

1.4

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

100

0.60

0.51

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.50

0.51

2.7

1.9

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

127

1.34

0.49

1.4

1.1

—

40.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.47

0.47

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.46

0.46

1.0

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

173

1.27

0.46

3.5

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.43

0.46

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

127

1162

1.10

0.45

3.7

4.0

ug/l

77.6

26.3

0.37

104

910

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

156

1.28

0.45

3.7

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

210

1.24

0.45

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

450

1.16

0.45

1.8

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

130

1.31

0.44

1.4

1.2

—

71.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

113

1.33

0.42

1.5

1.4

mmol/l

5.5

5.6

0.06

113

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.43

0.42

1.6

1.4

ug/l

8.5

8.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.56

0.42

1.4

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.41

0.42

3.0

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

194

1.24

0.42

2.0

1.6

—

25.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.52

0.41

4.0

2.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.52

0.41

8.0

5.3

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

2.1

—

4.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

1.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.1

—

(3014891) Appearance of Pleural fluid

0.00

0.40

0.0

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

358

0.84

0.40

1.5

1.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.47

0.40

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.47

0.40

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.47

0.40

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.33

0.40

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

150

1.27

0.40

1.6

1.5

—

(3022621) pH of Urine by Test strip

112

1027

1.10

0.40

3.1

2.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

207

2198

0.94

0.39

1.8

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.43

0.39

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.39

0.0

2.1

—

7.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

298

1.18

0.38

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.39

0.37

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.66

0.35

1.0

1.1

iu/ml

119.8

173.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

517

1.13

0.35

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.35

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

154

1.24

0.34

1.2

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

154

1.24

0.34

1.3

1.2

u/ml

0.1

0.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

938

0.91

0.33

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

937

0.91

0.33

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

937

0.91

0.33

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

408

1.13

0.31

3.0

3.6

u/ml

344.3

3457.3

0.69

351

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

933

0.92

0.31

1.3

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.32

0.30

1.4

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

138

1.23

0.30

1.5

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

231

1.17

0.29

2.7

2.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

388

0.87

0.29

1.1

u/ml

0.8

4.8

4.12

150

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.25

0.29

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

184

0.81

0.28

1.7

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

317

1.14

0.28

2.9

3.4

mg/l

22.4

23.1

0.06

206

(3023430) Cat dander IgE Ab [Units/volume] in Serum

354

0.87

0.27

1.1

u/ml

5.4

4.9

—

144

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

117

0.77

0.27

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

118

0.76

0.27

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

215

1.16

0.26

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

171

0.82

0.26

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.28

0.26

1.9

1.7

—

772331.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.25

0.25

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

459

4474

1.03

0.24

1.8

1.7

—

(4211845)

0.72

0.24

1.8

2.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

328

0.88

0.23

1.1

u/ml

0.1

0.4

—

(3008898) HLA-B27 [Presence]

814

1.07

0.23

1.1

—

(3003694) ABO and Rh group [Type] in Blood

513

5247

0.97

0.23

1.5

1.6

—

(4146454)

106

1.23

0.23

2.5

2.8

—

(3025130) Human papilloma virus identified in Specimen

369

0.89

0.23

1.5

1.7

—

(3044007) Cell count panel - Peritoneal fluid

1.28

0.23

2.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

134

1.20

0.23

1.0

1.2

—

290.0

—

(4281824)

178

0.84

0.22

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

248

1.13

0.21

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

16.1

—

(1761868) Lipid panel - Serum or Plasma

653

6416

1.03

0.21

2.6

2.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

126

1.19

0.21

1.1

1.5

umol/l

10.0

10.7

0.20

117

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

557

1.08

0.20

1.8

1.6

iu/ml

0.1

0.2

0.04

101

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

567

1.08

0.20

1.7

2.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.20

0.0

1.4

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.20

0.0

2.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.25

0.20

3.7

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.25

0.20

3.7

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

111

0.81

0.20

1.0

2.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.23

0.20

1.8

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

461

1.09

0.20

1.1

u/ml

1.9

1.4

0.15

210

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

155

1.16

0.20

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.18

0.19

1.7

1.2

nmol/l

78.8

101.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.15

0.19

1.0

1.1

—

10.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.15

0.19

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

482

1.08

0.19

1.1

u/ml

4.8

7.1

0.34

270

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

693

0.94

0.18

1.5

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.21

0.17

4.6

6.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

455

0.92

0.17

1.1

u/ml

0.4

2.9

—

111

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

167

1.14

0.17

3.3

4.3

u/ml

22.3

101.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

556

0.93

0.16

1.2

—

(40768793) Breast Pathology biopsy report

432

0.92

0.16

1.2

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.11

0.16

1.3

1.1

—

(3045788) Cell count panel - Pleural fluid

1.10

0.15

1.1

1.5

—

(3003338) MCHC [Mass/volume]

1495

15033

0.98

0.15

23.5

14.2

g/l

332.3

332.6

0.61

1490

14922

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

585

0.94

0.15

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

140

0.86

0.15

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

517

1.07

0.15

1.3

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.79

0.14

1.0

1.1

—

(40768441) Liver Pathology biopsy report

112

1.16

0.14

1.1

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

312

3056

1.02

0.14

1.8

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

363

1.08

0.14

1.4

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

132

1.14

0.13

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.17

0.13

1.5

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

111

1147

0.97

0.11

1.4

—

(4034850)

504

1.05

0.11

11.7

8.6

—

(3000492) Spirometry study

171

1672

1.02

0.10

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.11

0.09

1.8

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

330

1.06

0.09

1.1

u/ml

2.1

0.02

178

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.15

0.09

1.0

1.1

miu/ml

1281.2

1600.4

—

(44813793)

145

1.10

0.09

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

527

1.04

0.09

1.2

1.1

u/ml

0.4

1.5

2.66

225

(3017704) Immunofixation for Urine

1.09

0.09

2.8

1.5

—

(40768795) Lymph node Pathology biopsy report

134

0.89

0.08

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

107

1.12

0.08

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

107

1.12

0.08

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

117

1.11

0.08

1.3

1.2

—

(3020491) Glucose [Moles/volume] in Blood

133

0.90

0.07

1.2

1.6

mmol/l

6.3

6.4

—

(3006462) Nitrate [Presence] in Urine

0.83

0.07

1.8

2.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.85

0.07

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

228

2313

0.98

0.07

2.1

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

363

1.05

0.07

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

404

1.04

0.06

2.5

2.3

umol/l

5.4

4.7

0.41

300

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

513

1.03

0.06

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

890

0.98

0.06

1.4

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

169

1.07

0.05

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

525

1.03

0.05

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

140

1.07

0.04

1.1

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

182

1840

0.99

0.04

1.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

101

1.09

0.04

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

371

0.97

0.03

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

260

1.04

0.03

1.4

1.6

mmol/l

7.0

7.5

0.55

156

(3003740) Influenza virus B Ag [Presence] in Specimen

370

0.97

0.03

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

289

0.97

0.02

1.4

mmol/l

6.8

7.0

0.21

203

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

321

1.03

0.02

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

402

4034

1.00

0.02

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

135

0.96

0.00

4.5

2.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

145

0.97

0.00

1.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

144

0.97

0.00

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

144

0.97

0.00

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

144

0.97

0.00

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

144

0.97

0.00

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

144

0.97

0.00

1.4

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

316

1.01

0.00

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

148

1.01

0.00

2.5

3.1

nmol/l

0.8

0.9

—

118

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

107

1.03

0.00

3.8

3.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

177

1.02

0.00

1.4

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

827

1.00

0.00

1.5

1.6

mg/l

3.9

4.3

0.15

561

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

2.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

7.7

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

40.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.1

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

1.4

—

3.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

1.4

—

(3001729) Color of Synovial fluid

0.00

0.0

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.96

0.00

10.1

1.7

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

30.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3034426) Prothrombin time (PT)

0.87

0.00

1.0

1.3

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

66.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.91

0.00

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3024263) Appearance of Synovial fluid

0.95

0.00

1.7

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.92

0.00

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.02

0.00

2.8

2.1

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPERPIT and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPERPIT	1.864 [1.59, 2.18]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.314

During the follow-up period (1.1.1998 — 31.12.2019), 660 out of 7880 females with E4_HYPERPIT died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPERPIT	1.915 [1.63, 2.25]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.036

During the follow-up period (1.1.1998 — 31.12.2019), 521 out of 2276 males with E4_HYPERPIT died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPERPIT.

N-year risk	Females	Males
1	0.217%	0.38%
5	1.083%	2.337%
10	2.632%	6.055%
15	5.096%	10.909%
20	9.329%	18.171%

Relationships between endpoints

↥

Index endpoint: E4_HYPERPIT – Hyperfunction of pituitary gland

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hyperfunction of pituitary gland

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints